This article was initially published with an error in email address of corresponding author. At the request of the author, the affiliation of the first author is replaced as follows “Department of Nuclear Medicine, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.” The authors apologize for any inconvenience that this may have caused.
. 2020 Oct 6;23(5):577. doi: 10.4048/jbc.2020.23.e54
Corrigendum: Myeloid-Derived Suppressor Cells Recruited by Chemokine (C-C Motif) Ligand 3 Promote the Progression of Breast Cancer via Phosphoinositide 3-Kinase-Protein Kinase B-Mammalian Target of Rapamycin Signaling
Anqi Luo
1, Min Meng
2, Guanying Wang
3, Rui Han
4, Yujiao Zhang
3, Xin Jing
3, Lin Zhao
3, Shanzhi Gu
5, Xinhan Zhao
3
Anqi Luo
1Department of Nuclear medicine, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Find articles by Anqi Luo
Min Meng
2Department of Oncology, Shandong Provincial Hospital Affiliated with Shandong University, Jinan, China.
Find articles by Min Meng
Guanying Wang
3Department of Oncology, First Affiliated Hospital of Medical School of Xi'an Jiaotong University, Xi'an, China.
Find articles by Guanying Wang
Rui Han
4Department of Oncology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Find articles by Rui Han
Yujiao Zhang
3Department of Oncology, First Affiliated Hospital of Medical School of Xi'an Jiaotong University, Xi'an, China.
Find articles by Yujiao Zhang
Xin Jing
3Department of Oncology, First Affiliated Hospital of Medical School of Xi'an Jiaotong University, Xi'an, China.
Find articles by Xin Jing
Lin Zhao
3Department of Oncology, First Affiliated Hospital of Medical School of Xi'an Jiaotong University, Xi'an, China.
Find articles by Lin Zhao
Shanzhi Gu
5Department of Forensic Medicine, Medical School of Xi'an Jiaotong University, Xi'an, China.
Find articles by Shanzhi Gu
Xinhan Zhao
3Department of Oncology, First Affiliated Hospital of Medical School of Xi'an Jiaotong University, Xi'an, China.
Find articles by Xinhan Zhao
1Department of Nuclear medicine, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
2Department of Oncology, Shandong Provincial Hospital Affiliated with Shandong University, Jinan, China.
3Department of Oncology, First Affiliated Hospital of Medical School of Xi'an Jiaotong University, Xi'an, China.
4Department of Oncology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
5Department of Forensic Medicine, Medical School of Xi'an Jiaotong University, Xi'an, China.
Collection date 2020 Oct.
© 2020 Korean Breast Cancer Society
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
PMCID: PMC7604377 PMID: 33154835
